Afamelanotide Implants Effectively Reduce Pain and Prolong Sun-Tolerance in Patients with Erythropoïetic Protoporphyria; Results of a Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Proceedings article published in 2013 by
J. Langendonk,
F. Karstens,
E. Sijbrands,
S. Hanneken,
A. Anstey,
J. C. Deybach,
R. Kauppinen,
L. Rhodes,
J. Frank,
G. Murphy,
F. W. M. de Rooij,
J. H. P. Wilson
